Predictions
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.32
28.12.20
28.12.20
€140.00
28.12.21
28.12.21
20.17%
29.12.21
29.12.21
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.32
28.12.20
28.12.20
€140.00
28.12.21
28.12.21
20.17%
29.12.21
29.12.21
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21